Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of ...

Indeed, the pathogen seems like ancient history — but as recent developments indicate, tuberculosis isn’t done with us yet.

Announcing a new article publication for Zoonoses journal. This study was aimed at exploring pulmonary tuberculosis (PTB) epidemiological characteristics and trends in China from 2016 to 2022 ...

Researchers have engineered two mycobacterial strains with built-in kill switches that trigger self-destruction after immune ...

Persons who were 15 years of age or older with fluoroquinolone-susceptible, pulmonary rifampin-resistant tuberculosis that was confirmed by WHO-endorsed rapid tests were enrolled at 12 sites ...

A landmark review in Molecular Biomedicine outlines cutting-edge strategies to combat tuberculosis (TB), highlighting novel vaccines, AI-driven antigen discovery, and next-gen therapies to address ...

A new LNP-mRNA vaccine significantly boosts immune response and enhances BCG protection against tuberculosis, offering a ...

vaccine against pulmonary TB; the low overall risk of infection with M. tuberculosis in the United States; and the vaccine’s interference with the interpretation of the TB skin test.” ...

In an interview with The American Journal of Managed Care, Michael A. Bernstein, MD, stressed the need for effective ...

Over 200 visitors interacted with each other over themes of drug resistant tuberculosis, extra-pulmonary TB and developments ...